A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals

ConclusionsThis study demonstrated that systemic exposure to budesonide after a single oral dose of BOS 2  mg was lower than that after a single oral dose of ENTOCORT EC 9 mg. These results provide PK bridging data to compare BOS with therapeutic doses of ENTOCORT EC with respect to safety information.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research